Siren, L.L.C. Xenon Pharmaceuticals Inc. Transaction History
Siren, L.L.C.
- $1.76 Trillion
- Q1 2025
A detailed history of Siren, L.L.C. transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Siren, L.L.C. holds 732,761 shares of XENE stock, worth $21.6 Million. This represents 1.4% of its overall portfolio holdings.
Number of Shares
732,761
Previous 743,769
1.48%
Holding current value
$21.6 Million
Previous $29.2 Billion
15.68%
% of portfolio
1.4%
Previous 1.29%
Shares
2 transactions
Others Institutions Holding XENE
# of Institutions
219Shares Held
69.9MCall Options Held
444KPut Options Held
207K-
Avoro Capital Advisors LLC New York, NY5.74MShares$169 Million3.12% of portfolio
-
Driehaus Capital Management LLC Chicago, IL4.58MShares$135 Million1.68% of portfolio
-
Wellington Management Group LLP Boston, MA3.79MShares$112 Million0.03% of portfolio
-
Janus Henderson Group PLC London, X03.33MShares$98 Million0.06% of portfolio
-
Capital International Investors Los Angeles, CA3.09MShares$91 Million0.02% of portfolio
About Xenon Pharmaceuticals Inc.
- Ticker XENE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,263,500
- Market Cap $1.83B
- Description
- Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...